Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$61.59+1.26 (+2.09%)
Close on Nov 13, 2026Market cap $9.55BP/E –Yield –
Bruker total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bruker's total debt was $1.71B at Sep 30, 2026. For fiscal 2025 it was $1.87B, down 10.8% from the year before. Over ten years it grew 21.5% a year on average. The highest annual figure on record is $2.09B in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | -10.8% |
| FY2024 | Dec 31, 2024 | $2.09B | +63.4% |
| FY2023 | Dec 31, 2023 | $1.28B | +5.1% |
| FY2022 | Dec 31, 2022 | $1.22B | -8.6% |
| FY2021 | Dec 31, 2021 | $1.33B | +58.0% |
| FY2020 | Dec 31, 2020 | $844.50M | +3.8% |
| FY2019 | Dec 31, 2019 | $813.30M | +138.4% |
| FY2018 | Dec 31, 2018 | $341.10M | -17.9% |
| FY2017 | Dec 31, 2017 | $415.60M | +0.9% |
| FY2016 | Dec 31, 2016 | $411.70M | +54.9% |
| FY2015 | Dec 31, 2015 | $265.80M | -25.1% |
| FY2014 | Dec 31, 2014 | $355.00M | 0.0% |
| FY2013 | Dec 31, 2013 | $355.00M | +5.3% |
| FY2012 | Dec 31, 2012 | $337.20M | +11.3% |
| FY2011 | Dec 31, 2011 | $303.10M | +0.7% |
| FY2010 | Dec 31, 2010 | $301.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.71B | -14.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.82B | -25.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.67B | -20.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.87B | -10.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.01B | -12.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.44B | +12.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.11B | +53.3% |
| Q4 FY2024 | Dec 31, 2024 | $2.09B | +63.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.30B | +88.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.16B | +73.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.38B | +12.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.28B | +5.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.22B | +5.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.24B | +4.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.23B | +1.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.22B | -8.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.15B | +39.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.19B | +42.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.22B | +47.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.33B | +58.0% |
| Q3 FY2021 | Sep 30, 2021 | $827.00M | -0.3% |
| Q2 FY2021 | Jun 30, 2021 | $829.30M | -19.1% |
| Q1 FY2021 | Mar 31, 2021 | $824.20M | -18.4% |
| Q4 FY2020 | Dec 31, 2020 | $844.50M | +3.8% |
| Q3 FY2020 | Sep 30, 2020 | $829.90M | +60.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.02B | +107.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.01B | +202.0% |
| Q4 FY2019 | Dec 31, 2019 | $813.30M | +138.4% |
| Q3 FY2019 | Sep 30, 2019 | $518.80M | +115.6% |
| Q2 FY2019 | Jun 30, 2019 | $494.20M | +124.0% |
| Q1 FY2019 | Mar 31, 2019 | $334.60M | +51.7% |
| Q4 FY2018 | Dec 31, 2018 | $341.10M | -17.9% |
| Q3 FY2018 | Sep 30, 2018 | $240.60M | -49.9% |
| Q2 FY2018 | Jun 30, 2018 | $220.60M | -48.8% |
| Q1 FY2018 | Mar 31, 2018 | $220.60M | -42.7% |
| Q4 FY2017 | Dec 31, 2017 | $415.60M | +0.9% |
| Q3 FY2017 | Sep 30, 2017 | $480.50M | – |
| Q2 FY2017 | Jun 30, 2017 | $430.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $384.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $411.70M | – |
See a number that looks wrong?